Assignee
AUCENTRA THERAPEUTICS PTY LTD
AU·4 granted patents·7 pending applications·0 citations·filing 2016–2023
Top patents by PatentIndex Score
11 records- 0170US11970491B2N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compoundsAUCENTRA THERAPEUTICS PTY LTD·Filed 2021·Granted Apr 30, 2024·0 cites·17 claims
- 0261US2025049796A1Use of 4-thiazol-n-(pyridin-2-yl)pyrimidin-2-amine derivatives in combination therapies for cancerAUCENTRA THERAPEUTICS PTY LTD·Filed 2023·Application pending·0 cites
- 0361US2025049795A1Use of 5-(2-((5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)amino)-5-fluoropyrimidin-4-yl)-n,4-dimethylthiazol-2-amine in combination therapies for cancerAUCENTRA THERAPEUTICS PTY LTD·Filed 2023·Application pending·0 cites
- 0456US2023092876A15-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agentsAUCENTRA THERAPEUTICS PTY LTD·Filed 2022·Application pending·0 cites
- 0555USRE49850EN-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compoundsAUCENTRA THERAPEUTICS PTY LTD·Filed 2016·Granted Feb 27, 2024·0 cites·41 claims
- 0653US2023339889A1Derivatives of 2-oxo-n-(4-(pyrimidin-4-yloxy/thio)phenyl)-1,2-dihydropyridine-3-carboxamide for use as protein kinase inhibitors for therapyAUCENTRA THERAPEUTICS PTY LTD·Filed 2021·Application pending·0 cites
- 0752US2023181580A1Treatment of proliferative diseases of the cnsAUCENTRA THERAPEUTICS PTY LTD·Filed 2021·Application pending·0 cites
- 0851US2023399325A1Succinate and crystal form thereof as therapeuticsAUCENTRA THERAPEUTICS PTY LTD·Filed 2021·Application pending·0 cites
- 0950US12398132B2Derivatives of 4-(imidazo[1,2-a]pyridin-3-yl)-n-(pyridinyl)pyrimidin-2-amine as therapeutic agentsAUCENTRA THERAPEUTICS PTY LTD·Filed 2020·Granted Aug 26, 2025·0 cites·15 claims
- 1043US2024158391A1Derivatives of 4-(imidazo[1,2-a]pyridin-3-yl)-n-(pyridin-3-yl) pyrimidin-2- amine for treating proliferative diseases and conditionsAUCENTRA THERAPEUTICS PTY LTD·Filed 2020·Application pending·0 cites
- 1133US11111245B2Derivatives of N-cycloalkyl/heterocycloalkyl-4-(imidazo[1,2-a]pyridine)pyrimidin-2-amine as therapeutic agentsAUCENTRA THERAPEUTICS PTY LTD·Filed 2018·Granted Sep 7, 2021·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when AUCENTRA THERAPEUTICS PTY LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →